Real-world evidence speaks louder than biological plausibility. Editorial on “Ursodeoxycholic acid and long COVID in steatotic liver disease: a nationwide cohort study”
Clinical and Molecular Hepatology · 29.10.2026
DOI: 10.3350/cmh.2026.0966 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 29.10.2026. Verfasst von Tian-Yi Ren und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. fanjiangao@xinhuamed.com.cn.
- Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai, China. fanjiangao@xinhuamed.com.cn.
Zitieren
APA
Ren, T. Y., & Fan, J. G. (2026). Real-world evidence speaks louder than biological plausibility. Editorial on “Ursodeoxycholic acid and long COVID in steatotic liver disease: a nationwide cohort study”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0966
Vancouver
Ren TY, Fan JG. Real-world evidence speaks louder than biological plausibility. Editorial on “Ursodeoxycholic acid and long COVID in steatotic liver disease: a nationwide cohort study”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0966
BibTeX
@article{Ren2026,
author = {Ren, Tian-Yi and Fan, Jian-Gao},
title = {Real-world evidence speaks louder than biological plausibility. Editorial on “Ursodeoxycholic acid and long COVID in steatotic liver disease: a nationwide cohort study”},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0966}
}
EUVIMED